{"status": "OK", "response": {"docs": [{"type_of_material": "Article", "blog": [], "news_desk": null, "lead_paragraph": "NEW drugs are the key to the market performance of pharmaceutical stocks, as investors in SmithKline and Schering-Plough can attest. After the SmithKline Corporation voluntarily withdrew Selacryn, its antihypertension product, from the United States market because of unexpected ...", "headline": {"main": "Market Place; Impact of News On Drug Stocks"}, "abstract": "Robert Metz article on drug stocks observes that SmithKline and Schering-Plough Corps have found that success or failure of new drugs to be key factors in performance of pharmaceutical shares (M)", "print_page": "D6", "word_count": 821, "_id": "4fc4a4eb45c1498b0dab6156", "snippet": "NEW drugs are the key to the market performance of pharmaceutical stocks, as investors in SmithKline and Schering-Plough can attest.  After the SmithKline Corporation voluntarily withdrew Selacryn, its antihypertension product, from the United States...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://query.nytimes.com/gst/abstract.html?res=9906E7DD103EE732A2575BC1A9679C94619FD6CF", "multimedia": [], "subsection_name": null, "keywords": [{"name": "subject", "value": "DRUGS AND DRUG TRADE"}], "byline": {"person": [{"organization": "", "role": "reported", "firstname": "Robert", "rank": 1, "lastname": "Metz"}], "original": "Robert Metz"}, "document_type": "article", "pub_date": "1980-01-18T00:00:00Z", "section_name": null}], "meta": {"hits": 1, "offset": 0, "time": 30}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}